View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
December 19, 2018

Retia Medical secures FDA clearance for Argos CO Monitor

Medical device manufacturer Retia Medical has secured 510(k) clearance from the US Food and Drug Administration (FDA) to market its Argos Cardiac Output (CO) monitor.

Medical device manufacturer Retia Medical has secured 510(k) clearance from the US Food and Drug Administration (FDA) to market its Argos Cardiac Output (CO) monitor.

Argos is a hemodynamic monitor designed for tracking cardiac output and its derived parameters on patients in an intensive care unit (ICU) or operating room (OR).

The monitoring device provides the data necessary to monitor oxygen delivery and maintain optimal fluid status.

It uses the company’s Multi-Beat Analysis (MBA) Algorithm that uses advanced signal processing for accurate tracking of fluid and pressor resuscitation.

The monitor is only suitable for use on patients aged 18 or over.

“We designed Retia’s proprietary MBA algorithm to overcome the limitations of current CO monitoring technologies in order to realise the potentially life-saving benefits.”

Retia Medical co-founder and CEO Marc Zemel said: “A key challenge in realising the potential clinical benefits of CO monitoring is that many monitors fail to track CO changes accurately when fluid and vasoactive drug therapy are administered.

“We designed Retia’s proprietary MBA algorithm to overcome the limitations of current CO monitoring technologies in order to realise the potentially life-saving benefits that accurate and effective hemodynamic management can provide to patients.”

The device is designed to improve proactive clinical decision-making in cases of high-risk surgical and critically ill patients. Improvements can enhance outcomes in ICU and OR.

Argos is said to be a simple and cost-effective solution as it avoids disposable costs. The device can be easily integrated with all vital signs monitors and common electronic medical record (EMR) systems.

It features an intuitive user interface, along with instant access to patients’ hemodynamic profiles from remote locations. The monitor can be adopted in a variety of care settings.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU